Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT02860156
Eligibility Criteria:
Inclusion Criteria:
1. Age \>40 years
2. Willingness and ability to provide informed consent
3. HIV antibody positive
4. On HAART for \>6 months (HIV positive cohort only)
5. History of adequate viral suppression as defined by HIV RNA level \<200 copies/mL in the past 6 months
6. LVEF \>50% -
Exclusion Criteria:
1. Past EF \<50%
2. Moderate or severe valve stenosis or regurgitation, or past repair or replacement
3. Percutaneous or surgical revascularization or active angina
4. Persistent atrial fibrillation
5. BP\>160mmHg SBP or \>100mmHg DBP
6. Comorbid inflammatory disease (e.g. RA or SLE)
7. Active cancer or cancer chemotherapy treatment in the prior year (except skin cancer that did not require chemotherapy or radiation)
8. Chronic use of steroids or anti-inflammatory therapy
9. GFR \<30 mL/min
10. Active in a clinical trial with investigational product
11. Pregnant or lactating females
12. Contraindication to cMR or gadolinium injection (such as severe claustrophobia, metal implants, etc.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT02860156
Study Brief:
Protocol Section:
NCT02860156